Clearside Biomedical, Inc.

CLSD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$20,020$28,920$48,418$30,436
Short-Term Investments$0$0$0$0
Receivables$507$170$0$10,000
Inventory$0$0$0$921
Other Curr. Assets$747$1,033$983$779
Total Curr. Assets$21,274$30,123$49,401$42,136
Property Plant & Equip (Net)$3,822$3,865$1,872$607
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$30$0
Tax Assets$0$0$0$0
Other NC Assets$30$30$0$160
Total NC Assets$3,852$3,895$1,902$767
Other Assets$0$0$0$0
Total Assets$25,126$34,018$51,303$42,903
Liabilities
Payables$1,452$2,205$1,050$941
Short-Term Debt$375$364$349$387
Tax Payable$0$0$0$0
Deferred Revenue$0$75$205$0
Other Curr. Liab.$2,967$4,169$4,179$3,312
Total Curr. Liab.$4,794$6,813$5,783$4,640
LT Debt$52,095$42,637$34,913$288
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$7,092$480$0$0
Total NC Liab.$59,187$43,117$34,913$288
Other Liabilities$0$0$0$0
Cap. Leases$703$649$936$675
Total Liabilities$63,981$49,930$40,696$4,928
Equity
Pref Stock$0$0$0$0
Common Stock$77$63$61$60
Retained Earnings-$355,275-$320,923-$288,438-$255,491
AOCI-$0$0$0$0
Other Equity$316,343$304,948$298,984$293,406
Total Equity-$38,855-$15,912$10,607$37,975
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$25,126$34,018$51,303$42,903
Net Debt$32,450$14,081-$13,156-$29,761